Published in J Recept Signal Transduct Res on May 06, 1997
An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. Cardiovasc Res (2010) 1.05
Pharmacological evidence for capacitative Ca(2+) entry in cannulated and pressurized skeletal muscle arterioles. Br J Pharmacol (2001) 0.87
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun (1985) 0.97
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol (1998) 0.90
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
Reaction of cysteine thiol groups with 1,3-propane sultone: S-3-sulphopropyl as a modifying group for protein chemistry. Int J Pept Protein Res (1974) 0.82
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol (1997) 0.80
Purification and chemical characterization of melittin and acetylated derivatives. Biochim Biophys Acta (1980) 0.80
Reduction of S-sulpho groups by tributylphosphine: an improved method for the recombination of insulin chains. Hoppe Seylers Z Physiol Chem (1975) 0.80
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1987) 0.80
Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils. Br J Pharmacol (1998) 0.80
4-pyridylmethyl, a thiol-protecting group suitable for the partial synthesis of proteins. Biochem J (1979) 0.79
Correlation between substance P content of primary sensory neurones and pain sensitivity in rats exposed to antibodies to nerve growth factor. Eur J Pharmacol (1982) 0.79
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J Cardiovasc Pharmacol (1991) 0.79
Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radic Biol Med (1999) 0.77
Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity. Am J Hypertens (1991) 0.76
Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. FEBS Lett (1986) 0.76
Antivasoconstrictor effects of isradipine. A quantitative approach in anesthetized rats and conscious rabbits. Am J Med (1989) 0.76
Reductive cleavage of S-sulfo groups with tributylphosphine. Methods Enzymol (1977) 0.76
2-Sulphobenzyl, a new solubilizing and reversible protecting group for cysteine in proteins. Its scope and limitations. Biochem J (1979) 0.75
Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol. Acta Physiol Scand (2002) 0.75
Inactivation and solubilization of opiate receptors by phospholipases A2. Biochim Biophys Acta (1982) 0.75
Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. J Cardiovasc Pharmacol (1993) 0.75
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75